GENE ONLINE|News &
Opinion
Blog

2026-04-06|

Four Corners Property Trust Secures $200 Million Seven-Year Term Loan Facility Based on SOFR

by GOAI
Share To

Four Corners Property Trust (FCPT) has secured a new seven-year, $200 million term loan facility, according to an announcement made on April 6, 2026. The company stated that the loan will carry a variable interest rate based on the Secured Overnight Financing Rate (SOFR), plus an applicable margin. FCPT plans to use the proceeds from this facility for general corporate purposes, including refinancing existing debt and funding future growth initiatives.

The term loan was arranged with a group of lenders, though specific details regarding the participating financial institutions were not disclosed. FCPT emphasized that this financing aligns with its ongoing strategy to maintain financial flexibility while supporting its long-term operational goals. The company also noted that the agreement reflects favorable terms in light of current market conditions. Further specifics about repayment schedules or additional covenants tied to the loan were not included in the announcement.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 6, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
[Illustrations] The Diversity Deficit in Oncology Trials: When Enrollment Logic No Longer Reflects Real-World Patients
2026-04-16
Japanese Researchers Identify Stem Cell Dynamics in Vocal Fold Tissue Maintenance and Repair
2026-04-16
Study Identifies Active Role of Skin Cells in Rabies Virus Replication and Transmission
2026-04-16
Contractor Fatality Halts Operations at ATEX Resources’ Valeriano Project in Chile
2026-04-15
Dual Inhibition of xCT and GGCT Induces Ferroptosis in Glioblastoma Cells
2026-04-15
Researchers Develop Method to Convert Ketones into Saturated Heterocycles for Pharmaceutical Applications
2026-04-15
Naturally Occurring Compounds Luteolin, Naringenin, and Scutellarin Identified as Potential Inhibitors of Breast Cancer-Linked Enzymes HDAC4 and HDAC8
2026-04-15
Scroll to Top